Saturday 17 October 2026
Export CLPT’s income statement to Excel — free account
ClearPoint Neuro, Inc.
CLPT Healthcare Medical Devices
ClearPoint Neuro, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $37.0 million, up 17.8% from fiscal 2024. In the quarter to June 2026, revenue grew 18.1%, EPS fell 81.0%, free cash flow fell 173.5% and total debt rose 74.1%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
9.07
0.57
−5.91%
Follow CLPT
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
4 | 4 | 2 | 3 | 4 | 3 | 4 | 4 | 6 | 3 |
P/S ratio |
10.48 | 13.24 | 6.94 | 9.79 | 14.27 | 19.63 | 5.63 | 2.33 | 2.77 | 1.63 |
Altman Z-Score |
0.44 | 11.08 | (1.36) | 3.17 | 6.07 | 0.54 | (7.74) | (18.02) | (8.85) | (19.13) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(4.93) | (13.52) | (11.26) | (3.48) | 0.74 | (9.58) | (29.14) | (44.72) | (22.07) | (45.53) |
Beneish M-Score |
(1.74) | (3.24) | (2.91) | (2.30) | (2.35) | (1.86) | (3.36) | (2.99) | (2.84) | (3.82) |
P/Operating CF |
(32.07) | (334.42) | (142.29) | (65.64) | (65.49) | (104.90) | (135.41) | (29.46) | (11.70) | (8.43) |
P/B ratio |
13.82 | 16.37 | 7.86 | 5.45 | 4.77 | 105.96 | 13.77 | 11.35 | 3.50 | 0.00 |
Price to Tangible BV |
58.46 | 16.44 | 8.00 | 5.52 | 4.82 | 140.86 | 15.47 | 24.20 | 4.12 | 0.00 |
EV/Sales |
10.56 | 12.92 | 6.40 | 8.45 | 11.56 | 19.73 | 5.32 | 2.66 | 2.18 | 2.57 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(16.33) | (45.32) | (11.17) | (10.74) | (14.84) | (32.42) | (20.92) | (4.22) | (2.68) | (2.54) |
EV/FCF |
(15.63) | (40.44) | (10.22) | (10.03) | (14.16) | (30.50) | (19.73) | (4.16) | (2.67) | (2.49) |
Quick Ratio |
4.87 | 2.40 | 3.55 | 5.92 | 11.88 | 6.87 | 1.77 | 2.32 | 2.33 | 1.39 |
Current Ratio |
5.91 | 3.22 | 4.87 | 7.54 | 13.02 | 7.96 | 2.71 | 3.56 | 2.90 | 2.02 |
Net Debt/EBITDA |
(0.14) | 1.13 | 0.63 | 1.78 | 3.52 | (0.25) | 1.00 | (0.08) | 0.75 | (0.17) |
Debt/Assets |
50.21% | 0.00% | 23.32% | 17.83% | 15.00% | 72.09% | 17.38% | 44.30% | 35.39% | 60.69% |
Debt/Equity |
1.75 | 0.00 | 0.47 | 0.27 | 0.20 | 8.95 | 0.45 | 2.30 | 0.84 | (5.94) |
Asset Turnover |
0.54 | 0.77 | 0.49 | 0.34 | 0.34 | 0.62 | 1.13 | 0.68 | 0.69 | 0.66 |
Operating CF/Net income |
0.94 | 0.47 | 0.62 | 0.98 | 0.88 | 1.15 | 0.51 | 0.75 | 0.84 | 0.72 |
Capex/Depreciation |
(0.22) | (0.14) | (0.69) | (1.38) | (0.21) | (0.33) | (0.16) | (0.09) | (0.05) | (0.17) |
Interest Coverage |
(10.12) | (38.10) | 58.15 | (201.63) | (13.75) | (4.31) | (4.81) | (5.35) | (7.26) | (7.12) |
| (95.64%) | (81.24%) | (76.09%) | (38.37%) | (56.33%) | (194.80%) | (181.73%) | (167.95%) | (282.59%) | 589.65% | |
| (37.30%) | (46.22%) | (45.01%) | (27.15%) | (30.31%) | (32.73%) | (56.01%) | (56.66%) | (67.30%) | (93.09%) | |
ROIC |
(48.45%) | (233.37%) | (175.75%) | (109.86%) | (185.09%) | (109.26%) | (298.16%) | (173.49%) | (271.78%) | (1,114.66%) |
Return on Tangible Assets |
(46.05%) | (75.61%) | (73.31%) | (36.36%) | (24.98%) | (30.03%) | (79.17%) | (119.33%) | (83.19%) | (237.66%) |
Average Days of Receivables |
64.66 | 54.80 | 48.93 | 47.33 | 52.33 | 53.52 | 35.47 | 61.25 | 46.96 | 54.97 |
Research and Development Expense of Revenue |
37.59% | 39.48% | 48.88% | 53.01% | 56.94% | 36.53% | 25.05% | 31.42% | 38.13% | 45.71% |
Selling, General and Administrative Expense of Revenue |
89.15% | 84.31% | 101.65% | 92.30% | 93.36% | 83.05% | 80.76% | 106.86% | 108.45% | 138.57% |
Intangible Assets out of Total Assets |
0.22 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | 0.04 | 0.10 | 0.06 | 0.13 |
Share Based Compensation of Revenue |
22.13% | 22.00% | 25.38% | 20.08% | 12.75% | 8.50% | 7.12% | 17.80% | 23.68% | 21.74% |
Graham Net Nets |
(0.02) | 0.05 | 0.09 | 0.16 | 0.19 | (0.01) | 0.05 | 0.02 | 0.23 | (0.22) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.43 |
Earnings Yield |
(6.65%) | (4.55%) | (13.46%) | (8.17%) | (5.97%) | (2.64%) | (8.96%) | (35.67%) | (42.42%) | (93.59%) |
Free Cash Flow Yield |
(6.45%) | (2.41%) | (9.01%) | (8.61%) | (5.72%) | (3.30%) | (4.79%) | (27.36%) | (29.47%) | (63.21%) |
Revenue per Share |
1.31 | 1.16 | 0.97 | 0.85 | 0.79 | 0.81 | 0.85 | 0.67 | 0.95 | 2.09 |
Operating CF per Share |
(0.84) | (0.33) | (0.56) | (0.67) | (0.61) | (0.49) | (0.22) | (0.42) | (0.77) | (2.11) |
Capex per Share |
(0.02) | (0.01) | (0.04) | (0.05) | (0.01) | (0.03) | (0.01) | (0.01) | 0.00 | (0.04) |
Free Cash Flow per Share |
(0.86) | (0.34) | (0.60) | (0.72) | (0.62) | (0.52) | (0.23) | (0.43) | (0.78) | (2.15) |
Cash per Share |
1.62 | 0.74 | 0.94 | 1.55 | 2.61 | 1.27 | 0.43 | 0.28 | 1.20 | 1.20 |
Shareholders Equity per Share |
0.99 | 0.94 | 0.86 | 1.53 | 2.35 | 0.15 | 0.35 | 0.14 | 0.75 | (0.27) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.99 | 0.94 | 0.86 | 1.53 | 2.35 | 0.15 | 0.35 | 0.14 | 0.75 | (0.27) |
Free Cash Flow |
(24.45) | (9.22) | (14.77) | (17.31) | (12.86) | (8.29) | (3.01) | (4.69) | (6.02) | (5.92) |
Working Capital |
52.84 | 23.01 | 28.74 | 44.39 | 57.14 | 22.26 | 6.55 | 4.79 | 8.35 | 3.07 |
Capital Expenditures |
(0.52) | (0.27) | (1.05) | (1.15) | (0.17) | (0.48) | (0.16) | (0.06) | (0.03) | (0.10) |
Net Current Asset Value |
(6.13) | 19.56 | 14.68 | 32.58 | 45.10 | (1.68) | 3.04 | 0.31 | 4.68 | (2.07) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.01 | 0.04 | 0.06 | 0.01 | 0.04 | 0.01 | 0.01 | 0.00 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.89 | 0.97 | 1.09 | 1.03 | 1.47 | 4.51 | 2.19 | 1.78 | 2.03 | 1.77 |
Cash ROIC |
(19.87%) | (20.28%) | (27.22%) | (20.54%) | (11.41%) | (18.94%) | (24.36%) | (58.00%) | (30.04%) | (83.97%) |
Accounts Receivable Turnover |
6.57 | 7.92 | 8.15 | 8.22 | 7.73 | 8.64 | 9.65 | 6.74 | 8.13 | 5.52 |
Accounts Payable Turnover |
11.00 | 14.16 | 31.10 | 20.09 | 14.24 | 5.86 | 5.37 | 3.86 | 2.51 | 2.35 |
Inventory Turnover |
1.88 | 1.66 | 1.20 | 0.99 | 1.27 | 1.15 | 1.47 | 1.10 | 1.42 | 1.48 |
Average Days of Payables |
32.11 | 39.87 | 13.87 | 14.14 | 30.11 | 29.52 | 89.44 | 75.14 | 95.62 | 213.64 |
Days of Inventory on Hand |
213.67 | 204.19 | 279.23 | 483.70 | 348.22 | 318.65 | 300.00 | 315.93 | 291.39 | 244.24 |
Average Receivables |
5.63 | 3.96 | 2.94 | 2.50 | 2.11 | 1.49 | 1.16 | 1.09 | 0.91 | 1.04 |
Average Payables |
1.30 | 0.87 | 0.33 | 0.35 | 0.36 | 0.63 | 0.73 | 0.63 | 1.15 | 1.12 |
Average Inventory |
7.61 | 7.39 | 8.61 | 7.12 | 4.09 | 3.24 | 2.67 | 2.21 | 2.04 | 1.79 |
Average Assets |
68.47 | 40.93 | 49.08 | 60.54 | 47.55 | 20.72 | 9.89 | 10.88 | 10.65 | 8.67 |
Average Common Equity |
26.70 | 23.28 | 29.03 | 42.84 | 25.58 | 3.48 | 3.05 | 3.67 | 2.54 | (1.37) |
Columns are period end dates